Skip to main content

Medical Oncology

Ausgabe 12/2014

Inhalt (54 Artikel)

Original Paper

Functional polymorphisms of circadian negative feedback regulation genes are associated with clinical outcome in hepatocellular carcinoma patients receiving radical resection

Zhaohui Zhang, Fei Ma, Feng Zhou, Yibing Chen, Xiaoyan Wang, Hongxin Zhang, Yong Zhu, Jianwei Bi, Yiguan Zhang

Original Paper

Prognosis in very young women with triple-negative breast cancer: retrospective study of 216 cases

Ying Liu, Tao Xin, Da-yong Huang, Wei-xi Shen, Li Li, Yan-ju Lv, Ying-hua Jin, Xiao-wei Song, Chong Teng, Qiu-ying Jiang

Original Paper

RETRACTED ARTICLE: A randomized phase II study of everolimus for advanced pancreatic neuroendocrine tumors in Chinese patients

Jun Yao, Jian-yao Wang, Yi Liu, Bin Wang, Ying-xue Li, Ru Zhang, Li-Sheng Wang, Lei Liu

Original Paper

X-linked inhibitor of apoptosis-associated factor l (XAFl) enhances the sensitivity of colorectal cancer cells to cisplatin

Wen-Cui Ju, Guo-Bin Huang, Xiao-Yong Luo, Wei-Hua Ren, De-Qing Zheng, Pin-Jia Chen, Yun-Feng Lou, Bin Li

Original Paper

The clinical research of the endoscopic sequential treatment for patients with intermediate–advanced esophageal cancer: a randomized clinical trial

Liming Wen, Honglin Quan, Linyan Li, Chun Huang, Xiaohui Chen, Yaling Yang, Liming Wang, Xiguo He, Xudong Zhang

Original Paper

Pokemon enhances proliferation, cell cycle progression and anti-apoptosis activity of colorectal cancer independently of p14ARF–MDM2–p53 pathway

Yi Zhao, Yun-hong Yao, Li Li, Wei-fang An, Hong-zen Chen, Li-ping Sun, Hai-xian Kang, Sen Wang, Xin-rong Hu

Original Paper

Prognostic value of carbohydrate tumor markers and inflammation-based markers in metastatic or recurrent gastric cancer

Qing Wang, Yang Yang, Ya-ping Zhang, Zhengyun Zou, Xiaoping Qian, Baorui Liu, Jia Wei

Original Paper

Perforin, CD28 and CD95 expression in circulating CD4 and CD8 cells as predictors of head and neck (H&N) cancer patient survival

Nongnit Laytragoon-Lewin, Fredrik Jönson, Jan Lundgren, Lars Erik Rutqvist, Anders Wikby, Sture Löfgren, Freddi Lewin

Original Paper

Negative feedback of miR-29 family TET1 involves in hepatocellular cancer

Li Li Lin, Wei Wang, ZhaoYang Hu, Li Wen Wang, Jing Chang, HanGuang Qian

Original Paper

Prediction and identification of HLA-A*0201-restricted epitopes from leukemia-associated protein MLAA-22 which elicit cytotoxic T lymphocytes

Jing Li, Ju Bai, Liufang Gu, Aili He, Jin Wang, Jianli Wang, Pengyu Zhang, Wanggang Zhang

Original Paper

Association between polymorphism of GLI1 gene SNP rs2228226 and chronic lymphocytic leukemia in Chinese population

Yuan-Yuan Li, Tian Tian, Run Zhang, Li Wang, Ji Xu, Lei Fan, Jian-Yong Li, Wei Xu

Original Paper

Resistive index of prostatic capsular arteries as a predictor of prostate cancer in patients undergoing initial prostate biopsy

Xuefeng Zhang, Gang Li, Linkun Hu, Xuedong Wei, Yueqin Zha, Huming Yin, Mubin Sun, Jun He, Jianquan Hou

Original Paper

Three dysregulated microRNAs in serum as novel biomarkers for gastric cancer screening

Hui Wang, Lei Wang, Zheng Wu, Rong Sun, Haifeng Jin, Jifeng Ma, Lili Liu, Rui Ling, Jun Yi, Ling Wang, Jiefang Bian, Jianghao Chen, Nanlin Li, Shifang Yuan, Jun Yun

Original Paper

Upregulation of microRNA-31 associates with a poor prognosis of malignant pleural mesothelioma with sarcomatoid component

Shinji Matsumoto, Kazuki Nabeshima, Makoto Hamasaki, Tatsuki Shibuta, Tsukuru Umemura

Open Access Original Paper

Expression of HIF-1α and CAIX in nasopharyngeal carcinoma and their correlation with patients’ prognosis

Yuhan Chen, Xianming Li, Shihai Wu, Gang Xu, Yayan Zhou, Long Gong, Zihuang Li, Dong Yang

Original Paper

The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients

Hou-Qun Ying, Qi-Wen Deng, Bang-Shun He, Yu-Qin Pan, Feng Wang, Hui-Ling Sun, Jie Chen, Xian Liu, Shu-Kui Wang

Original Paper

MicroRNA-146a rs2910164 polymorphism and the risk of diffuse large B cell lymphoma in the Chinese Han population

Haifeng Zhuang, Jianping Shen, Zhiyin Zheng, Xiusu Luo, Ruilan Gao, Xiaofen Zhuang

Original Paper

Re-challenge with catumaxomab in patients with malignant ascites: results from the SECIMAS study

Klaus Pietzner, Ignace Vergote, Armando Santoro, Radoslav Chekerov, Frederik Marmé, Per Rosenberg, Holger Martinius, Hilke Friccius-Quecke, Jalid Sehouli

Open Access Original Paper

Autologous hematopoietic stem cell transplantation for relapsed follicular lymphoma: safety profile and clinical outcome in a single-center experience

Grzegorz Helbig, Malgorzata Krawczyk-Kulis, Anna Kopinska, Robert Liwoch, Slawomira Kyrcz-Krzemien

Original Paper

MR imaging in hepatocellular carcinoma: correlations between MRI features and molecular marker VEGF

Zhaoqin Huang, Xiangjiao Meng, Jianjun Xiu, Xiuqin Xu, Lei Bi, Jie Zhang, Xue Han, Qingwei Liu

Original Paper

Clinical value of serum HMGB1 in diagnosis and prognosis of laryngeal squamous cell carcinoma

Guangbin Qiu, Yunhui Li, Zheng Liu, Mengran Wang, Jingjing Ge, Xiaozhong Bai

Original Paper

Downregulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinoma

You-Fang Chen, Gang Ma, Xun Cao, Zhi-Liang Huang, Mu-Sheng Zeng, Zhe-Sheng Wen

Original Paper

A prognostic model based on pretreatment platelet lymphocyte ratio for stage IE/IIE upper aerodigestive tract extranodal NK/T cell lymphoma, nasal type

Ke-feng Wang, Bo-yang Chang, Xiao-qin Chen, Pan-pan Liu, Zhi-jun Wuxiao, Zhi-hui Wang, Su Li, Wen-qi Jiang, Zhong-jun Xia

Open Access Original Paper

The expression of Toll-like receptors and development of severe sepsis in patients with acute myeloid leukemias after induction chemotherapy

Justyna Rybka, Aleksandra Butrym, Tomasz Wróbel, Bożena Jaźwiec, Ewa Stefanko, Olga Dobrzyńska, Rafał Poręba, Kazimierz Kuliczkowski

Original Paper

OSNA (one-step nucleic acid amplification) sentinel lymph node intraoperative molecular analysis in breast cancer: a cost-benefit analysis

Tiphaine Raia-Barjat, Béatrice Trombert, Abir Khaddage, Catherine Douchet, Pierre Seffert, Michel Peoc’h, Alexander Tuan Falk, Nicolas Magné, Céline Chauleur

Original Paper

Prognostic significance of the lymphocyte-to-monocyte ratio in patients with small cell lung cancer

Se-Il Go, Rock Bum Kim, Haa-Na Song, Myoung Hee Kang, Un Seok Lee, Hye Jung Choi, Seung Jun Lee, Yu Ji Cho, Yi Yeong Jeong, Ho Cheol Kim, Jong Deog Lee, Seok-Hyun Kim, Jung-Hun Kang, Hui Ling, Gyeong-Won Lee

Original Paper

Expression of MTA1 in nasopharyngeal carcinoma and its correlation with prognosis

Taize Yuan, Huanhuan Zhang, Baoqiong Liu, Qiong Zhang, Yin Liang, Ronghui Zheng, Jin Deng, Xiuping Zhang

Original Paper

The single nucleotide polymorphism +936 C/T VEGF is associated with human epidermal growth factor receptor 2 expression in Moroccan breast cancer women

Jalila Rahoui, Yassir Sbitti, Nadia Touil, Abdelilah Laraqui, Azeddine Ibrahimi, Brahim Rhrab, Abderrahman Al Bouzidi, Driss Moussaoui Rahali, Mohamed Dehayni, Mohamed Ichou, Fatima Zaoui, Saad Mrani

Original Paper

Upregulation of PDK1 associates with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro

Zhonglu Yang, Zhiyi Wu, Tao Liu, Lei Han, Chunhui Wang, Bo Yang, Fei Zheng

Original Paper

MiR-363 sensitizes cisplatin-induced apoptosis targeting in Mcl-1 in breast cancer

Ruiguang Zhang, Yan Li, Xiaochuan Dong, Li Peng, Xiu Nie

Original Paper

Overexpression of B7-H3 in CD14+ monocytes is associated with renal cell carcinoma progression

Miao Li, Guangbo Zhang, Xuefeng Zhang, Guanglin Lv, Xuedong Wei, Hexing Yuan, Jianquan Hou

Original Paper

Investigational tests and treatments performed in terminal stage cancer patients in two weeks before death: Turkish oncology group (TOG) study

İbrahim Türker, Şeref Kömürcü, Ali Arıcan, Hatice Doruk, Özgür Özyılkan, Hasan Şenol Coşkun, Dilşen Çolak, Emel Üçgül Çavuşoğlu, Alper Ata, Ahmet Sezer, Havva Yeşil Çınkır, Filiz Çay Şenler, Fikret Arpacı

Original Paper

Stereotactic body radiotherapy with concurrent chemotherapy extends survival of patients with limited stage small cell lung cancer: a single-center prospective phase II study

Chongyi Li, Yanli Xiong, Zejun Zhou, Yu Peng, Huan Huang, Mingfang Xu, Houyi Kang, Bo Peng, Dong Wang, Xueqin Yang

Original Paper

NCOA5 low expression correlates with survival in esophageal squamous cell carcinoma

Guan-qing Chen, Hui Tian, Wei-ming Yue, Lin Li, Shu-hai Li, Lei Qi, Cun Gao, Li-bo Si, Ming Lu

Review Article

Cell-free microRNAs as cancer biomarkers: the odyssey of miRNAs through body fluids

Mohammad Amin Javidi, Amir Hossein Ahmadi, Babak Bakhshinejad, Nazila Nouraee, Sadegh Babashah, Majid Sadeghizadeh

Review Article

Circulating tumor cells in breast cancer and its association with tumor clinicopathological characteristics: a meta-analysis

Yi Liao, Shu-Yi Wang, Xiang-Yu Meng, Jie Yang, Ming-Jun Shi, Hua-Long Liu, Fang-Fang Chen, Bin Xiong

Open Access Short Communication

Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy

Michael Hedenus, Torbjörn Karlsson, Heinz Ludwig, Beate Rzychon, Marcel Felder, Bernard Roubert, Gunnar Birgegård

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.